Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: Safety, response, and survival analysis

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 8, 2013, Pages 1227-1234

  Mouli, Samdeep ^a   Memon, Khairuddin ^a   Baker, Talia ^b   Benson III, Al B ^c   Mulcahy, Mary F ^c   Gupta, Ramona ^a   Ryu, Robert K ^a   Salem, Riad ^a,b,c   Lewandowski, Robert J ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; YTTRIUM 90;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BIOCHEMISTRY; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DRUG SAFETY; FATIGUE; FEMALE; FUNCTIONAL STATUS; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER TRANSPLANTATION; LOBECTOMY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PATIENT CODING; PEPTIC ULCER; PILOT STUDY; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; TREATMENT RESPONSE; VOMITING; WORLD HEALTH ORGANIZATION;

COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS; CTCAE; EASL; EASTERN COOPERATIVE ONCOLOGY GROUP; ECOG; EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER; ICC; INTRAHEPATIC CHOLANGIOCARCINOMA; OS; OVERALL SURVIVAL; PERFORMANCE STATUS; PS; RECIST; RESPONSE EVALUATION CRITERIA IN SOLID TUMORS; WHO; WORLD HEALTH ORGANIZATION;

AGED; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84880706993     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.02.031     Document Type: Article

References (30)

1. I. Endo, M. Gonen, and A.C. Yopp Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection Ann Surg 248 2008 84 96
2. A. Saxena, L. Bester, T.C. Chua, F.C. Chu, and D.L. Morris Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option Ann Surg Oncol 17 2010 484 491
3. J. Park, M.H. Kim, and K.P. Kim Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study Gut Liver 3 2009 298 305
4. J.C.C. Tan, N.G. Coburn, N.N. Baxter, A. Kiss, and C.H.L. Law Surgical management of intrahepatic cholangiocarcinoma - a population-based study Ann Surg Oncol 15 2008 600 608
5. J. Valle, H. Wasan, and D.H. Palmer Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 2010 1273 1281
6. J. Harder, B. Riecken, and O. Kummer Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer Br J Cancer 95 2006 848 852
7. J.S. Jang, H.Y. Lim, and I.G. Hwang Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial Cancer Chemother Pharmacol 65 2010 641 647
8. J.H. Kim, H.J. Won, Y.M. Shin, K.A. Kim, and P.N. Kim Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma AJR Am J Roentgenol 196 2011 W205 W209
9. G. Carrafiello, D. Laganà, and E. Cotta Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience Cardiovasc Intervent Radiol 33 2010 835 839
10. Y. Fu, W. Yang, and W. Wu Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma J Vasc Interv Radiol 23 2012 642 649
11. M.V. Kiefer, M. Albert, and M. McNally Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, Ethiodol, and polyvinyl alcohol: a 2-center study Cancer 117 2011 1498 1505
12. S.Y. Park, J.H. Kim, and H.J. Yoon Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma Clin Radiol 66 2011 322 328
13. H. Nathan, T.M. Pawlik, and C.L. Wolfgang Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER Database analysis J Gastrointest Surg 11 2007 1488 1496
14. M.K. Grove, R.E. Hermann, D.P. Vogt, and T.A. Broughan Role of radiation after operative palliation in cancer of the proximal bile ducts Am J Surg 161 1991 454 458
15. S.M. Ibrahim, M.F. Mulcahy, and R.J. Lewandowski Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study Cancer 113 2008 2119 2128
16. R.T. Hoffmann, P.M. Paprottka, and A. Schon Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival Cardiovasc Intervent Radiol 35 2012 105 116
17. R. Salem, R.J. Lewandowski, and K.T. Sato Technical aspects of radioembolization with 90Y microspheres Tech Vasc Interv Radiol 10 2007 12 29
18. M. Cirillo, M. Venturini, and L. Ciccarelli Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire Ann Oncol 20 2009 1929 1935
19. A. Forner, C. Ayuso, and M. Varela Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115 2009 616 623
20. G.A. Poultsides, A.X. Zhu, M.A. Choti, and T.M. Pawlik Intrahepatic cholangiocarcinoma Surg Clin North Am 90 2010 817 837
21. K. Hong, and J.F.H. Geschwind Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma Semin Oncol 37 2010 110 117
22. N.J. Gusani, F.K. Balaa, and J.L. Steel Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience J Gastrointest Surg 12 2008 129 137
23. I. Burger, K. Hong, and R. Schulick Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution J Vasc Interv Radiol 16 2005 353 361
24. C. Aliberti, G. Benea, M. Tilli, and G. Fiorentini Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results Cardiovasc Intervent Radiol 31 2008 883 888
25. G. Poggi, P. Quaretti, and C. Minoia Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors Anticancer Res 28 2008 3835 3842
26. R. Salem, R.J. Lewandowski, and M.F. Mulcahy Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes Gastroenterology 138 2010 52 64
27. Y. Murakami, K. Uemura, and T. Sudo Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma Ann Surg Oncol 18 2011 651 658
28. D. Ribero, A.D. Pinna, and A. Guglielmi Italian Intrahepatic Cholangiocarcinoma Study Group. Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients Arch Surg 147 2012 1107 1113
29. L. Kulik, B. Atassi, and L. van Holsbeeck Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation J Surg Oncol 94 2006 572 586
30. R.J. Lewandowski, L.M. Kulik, and A. Riaz A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization Am J Transplant 9 2009 1920 1928